These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2124632)

  • 1. [Studies on acetylspiramycin. II. Biological activities of spiramycin components].
    Kondo A; Sato K; Shuto K; Yamashita K; Ichikawa S; Takahashi K; Kita K; Nishiie Y; Sano H; Yamaguchi K
    Jpn J Antibiot; 1990 Sep; 43(9):1521-9. PubMed ID: 2124632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on acetylspiramycin. 1. Separation and chemical structures of acetylspiramycin components].
    Kondo A; Nakatani T; Kuzuya Y; Suzuki H; Sano H; Yamaguchi K; Shirahata K; Takahashi K; Kita K; Nishiie Y
    Jpn J Antibiot; 1990 Jun; 43(6):1152-63. PubMed ID: 2232146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The pharmacokinetic studies on spiramycin and acetylspiramycin in rats].
    Inoue A; Deguchi T
    Jpn J Antibiot; 1982 Aug; 35(8):1998-2004. PubMed ID: 7154248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interlaboratory study comparing the microbiological potency of spiramycins I, II and III.
    Liu L; Saevels J; Louis P; Nelis H; Rico S; Dierick K; Guyomard S; Roets E; Hoogmartens J
    J Pharm Biomed Anal; 1999 Jun; 20(1-2):217-24. PubMed ID: 10704026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the therapeutics of experimental toxoplasmosis. II. Effect of acetylspiramycin alone or in combination with an immunopotentiator (CSP-II) or sulfamethopyrazine on Toxoplasma multiplication in the heart of mice acutely and chronically infected with Toxoplasma gondii (author's transl)].
    Espinas FM; Takei Y; Sakurai H; Odakura Y; Suzuki N; Sasaki H
    Jpn J Antibiot; 1982 Feb; 35(2):362-8. PubMed ID: 7087173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro effect of (+)-usnic acid on Toxoplasma gondii tachyzoites].
    Wei LL; Cheng YB; Si KW; Gu N; Li XQ; Li C; Yuan YK
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec; 26(6):438-41. PubMed ID: 19288918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
    Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylspiramycin and the immune system. I. Effects of acetylspiramycin on phagocytosis by mouse macrophages in vitro and in vivo.
    Li SY; Nelson DS
    Int J Immunopharmacol; 1985; 7(6):881-8. PubMed ID: 4077347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impurity profiling of acetylspiramycin by liquid chromatography-ion trap mass spectrometry.
    Wang MJ; Pendela M; Hu CQ; Jin SH; Hoogmartens J; Van Schepdael A; Adams E
    J Chromatogr A; 2010 Oct; 1217(42):6531-44. PubMed ID: 20843520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial, anti-inflammatory activities and toxicology of phenylethanoid glycosides from Monochasma savatieri Franch. ex Maxim.
    Liu YL; He WJ; Mo L; Shi MF; Zhu YY; Pan S; Li XR; Xu QM; Yang SL
    J Ethnopharmacol; 2013 Sep; 149(2):431-7. PubMed ID: 23850835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
    Miwatani T; Takeda Y; Kotera K; Nishimura T; Takashima T; Hiromatsu K; Tabuki K; Fujimoto S; Kamiki T; Yoshizaki E; Yabuuchi E; Shimizu Y; Matsunaga K; Yamanaka K; Furuta I; Iimori M; Kodama J; Tanaka M; Maejima K; Nukina M; Takashima E; Takahashi M; Harikane O; Masutani T
    Jpn J Antibiot; 1983 Feb; 36(2):260-76. PubMed ID: 6304368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot evaluation of the anti-inflammatory activity of Culcasia scandens, a traditional antirheumatic agent.
    Okoli CO; Akah PA
    J Altern Complement Med; 2000 Oct; 6(5):423-7. PubMed ID: 11059504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo pharmacodynamic activity of the glycopeptide dalbavancin.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 2007 May; 51(5):1633-42. PubMed ID: 17307987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1991)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kondou T; Kobayashi K; Satou K; Matsumiya H; Saito A
    Jpn J Antibiot; 1995 Aug; 48(8):965-98. PubMed ID: 7474326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two novel spiramycins obtained from commercial samples: isolation and elucidation of structure.
    Liu L; Roets E; Busson R; Vankeerberghen A; Janssen G; Hoogmartens J
    J Antibiot (Tokyo); 1996 Apr; 49(4):398-401. PubMed ID: 8642006
    [No Abstract]   [Full Text] [Related]  

  • 16. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1995)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kawaguchi H; Shimizu Y; Matsumiya H; Saito A; Terai T; Inoue H; Nakadate T; Ito C; Yosida T; Tanno Y; Ohno I; Nishioka K; Arakawa M; Igarashi K; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Touyama M
    Jpn J Antibiot; 1997 May; 50(5):421-59. PubMed ID: 9212366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical modification of spiramycins. III. Synthesis and antibacterial activities of 4''-sulfonates and 4''-alkylethers of spiramycin I.
    Sano H; Sunazuka T; Tanaka H; Yamashita K; Okachi R; Omura S
    J Antibiot (Tokyo); 1984 Jul; 37(7):750-9. PubMed ID: 6469869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial mode of action of the hydroethanolic extract of Leonotis nepetifolia (L.) R. Br. involves bacterial membrane perturbations.
    Oliveira DM; Melo FG; Balogun SO; Flach A; de Souza EC; de Souza GP; Rocha Ido N; da Costa LA; Soares IM; da Silva LI; Ascêncio SD; de Oliveira Martins DT
    J Ethnopharmacol; 2015 Aug; 172():356-63. PubMed ID: 26102550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on josamycin. 3. (1) Bacteriological studies. (2) Protective effect against infections due to pathogenic bacteria. (3) Absorption, excretion, distribution in organs and in vivo activities].
    Osono T; Yano K; Mitamoto F; Watanabe S; Ishida H
    Jpn J Antibiot; 1969 Apr; 22(2):159-72. PubMed ID: 4389777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.